These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27926764)

  • 21. Intensive blood pressure/glucose control in type 2 diabetes: why is it so difficult to decrease coronary heart disease?
    Reaven GM
    J Hum Hypertens; 1999 Apr; 13 Suppl 2():S19-23; discussion S25-8. PubMed ID: 10335853
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart Failure and Hypertension: Importance of Prevention.
    Pfeffer MA
    Med Clin North Am; 2017 Jan; 101(1):19-28. PubMed ID: 27884228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin.
    Avogaro A; Fadini GP
    Diabetes Obes Metab; 2018 Jun; 20(6):1367-1368. PubMed ID: 29377537
    [No Abstract]   [Full Text] [Related]  

  • 24. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 25. [Decreased blood pressure helps every diabetic patient long term].
    Zidek W
    MMW Fortschr Med; 2015 Apr; 157(6):36. PubMed ID: 26015199
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypertension and heart failure.
    Nicholls MG; Richards AM; Begg EJ
    Adv Exp Med Biol; 1997; 432():273-9. PubMed ID: 9433534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Type 2 diabetes mellitus and heart failure].
    Linhart A; Bělohlávek J
    Vnitr Lek; 2016; 62(7-8):592-7. PubMed ID: 27627083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension and diabetes: target blood pressure and blood pressure lowering by new antidiabetic drugs].
    Kintscher U; Jacob S
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2468-9. PubMed ID: 25409409
    [No Abstract]   [Full Text] [Related]  

  • 29. Heart failure: treatment and ethnic origin.
    McKenzie DB; Wilcox RG
    Lancet; 2003 Sep; 362(9387):919. PubMed ID: 13678990
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin syndrome during a heat wave.
    Puig-Comas G; García-Peláez M; Gorgas Torner MQ; Pontes García C
    Emergencias; 2018 Feb; 30(1):62-63. PubMed ID: 29437313
    [No Abstract]   [Full Text] [Related]  

  • 31. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
    El Aassri H; El Mghari G; El Ansari N
    Pan Afr Med J; 2014; 17():193. PubMed ID: 25396019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CHARM].
    Momomura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():431-6. PubMed ID: 16981575
    [No Abstract]   [Full Text] [Related]  

  • 33. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk.
    Sciarretta S; Palano F; Tocci G; Baldini R; Volpe M
    Arch Intern Med; 2011 Mar; 171(5):384-94. PubMed ID: 21059964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension, hypertrophy, heart failure.
    Nicholls MG
    Heart; 1996 Nov; 76(3 Suppl 3):92-7. PubMed ID: 8983668
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DSAM, diabetes and hypertension].
    Bak JF; Poulsen PL; Schmitz AC
    Ugeskr Laeger; 2003 Jan; 165(3):245-6; author reply 246. PubMed ID: 12555714
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertension plus diabetes. Lowering blood pressure is first priority].
    MMW Fortschr Med; 1999 Sep; 141(38):55. PubMed ID: 10904621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.